Onyx Pharmaceuticals Inc. (ONXX) Reports Q4 Loss of 28c
Tweet Send to a FriendGet Alerts ONXX Hot Sheet
Price: $95.66 +2.83%
Revenue Growth %: +102.1%
Financial Fact:
Interest expense: -5.63M
Today's EPS Names:
BOSC, GASS, AAP, More
Revenue Growth %: +102.1%
Financial Fact:
Interest expense: -5.63M
Today's EPS Names:
BOSC, GASS, AAP, More
Trade ONXX Now!
Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) reported Q4 EPS of ($0.28), $0.26 worse than the analyst estimate of ($0.02).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Childrens Place (PLCE) Tops Q1 EPS by 22c; Boosts Outlook
- Dollar Tree, Inc. (DLTR) Tops Q1 EPS by 2c; Issues Muted Outlook
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
